Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-004660)

Filing Details

Accession Number:: 0001209191-13-004660
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-01-28 17:04:55
Reporting Period:: 2013-01-25

Filing Date:: 2013-01-28
Accepted Time:: 2013-01-28 17:04:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
907654	Arca Biopharma Inc.	ABIO	In Vitro & In Vivo Diagnostic Substances (2835)	363855489

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1266125	R Michael Bristow	8001 Arista Place Suite 430 Broomfield CO 80021	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-01-25	1,069,290	$0.47	1,069,290	No	4	P	Indirect	By NFS Custodian for Michael Bristow's IRA

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By NFS Custodian for Michael Bristow's IRA

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common stock warrants (right to buy)	Acquisiton	2013-01-25	748,503	$0.00	748,503	$0.38

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
748,503	2013-01-25	2020-01-25	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	834,495	Indirect	By Investocor Trust as sole trustee
Common Stock	280,071	Direct

Footnotes

The warrants are fully vested and exercisable upon issuance and have a contractual term of 7 years.